logo

Shariah compliance overview

Not Halal

Stoke Therapeutics, Inc. (STOK) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States.

Stoke Therapeutics, Inc. (STOK) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity.

Business Activity
6.95%Limit 5%Fail
Interest-bearing debt
0.00%Limit 30%Pass
Interest-bearing securities and assets
25.83%Limit 30%Pass
Dividend purification
6.95%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Stoke Therapeutics, Inc. (STOK). Current Akinda screening label: Not Halal.